Ancient herbs take on kidney disease: new trial begins
NCT ID NCT07657338
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests whether adding a Chinese herbal formula called CKD-1 to standard care can improve kidney function in people with stage 3-4 non-diabetic chronic kidney disease. About 66 adults will be randomly assigned to receive either standard care alone or standard care plus the herbal formula for 12 weeks. Researchers will measure changes in kidney filtration rate, urine protein, and quality of life to see if the herbs offer any benefit.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chinese herbal formula CKD-1 (Astragalus, Salvia, Poria, Moutan, Scutellaria, Lonicera, Alisma)
- What this could lead to
- If it works, this could point toward a safe herbal add-on to help slow kidney decline in non-diabetic patients.
- What could go wrong
- This is a very small pilot study (66 people) with no blinding, so results may be unreliable. The herbal mix may not outperform standard care or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China Medical University Beigang Hospital
Yunlin, Taiwan, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.